Skip to content

Comparison of postoperative analgesia and recovery quality between intravenous lidocaine infusion and femoral nerve block in patients undergoing knee arthroscopic cruciate ligament repairment

Comparison of postoperative analgesia and recovery quality between intravenous lidocaine infusion and femoral nerve block in patients undergoing knee arthroscopic cruciate ligament repairment: A prospective, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062788
Enrollment
Unknown
Registered
2022-08-19
Start date
2022-08-25
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee disease

Interventions

intravenous lidocaine:intravenous lidocaine
Femoral nerve block group: femoral nerve block

Sponsors

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Knee arthroscopic cruciate ligament repairment; 2. Aged between 18 and 75 years old; 3. Signed informed consent; 4. Normal liver and kidney function; 5. ASA Grade 1 or 2.

Exclusion criteria

Exclusion criteria: 1. The patient refuses to participate; 2. allergic to local anesthetics and other drugs used; 3. liver and kidney dysfunction; 4. have a serious systemic disease, such as heart failure; 5. suffering from uncorrected malignant arrhythmia; 6. Somatosensory dysfunction; 7. The presence of central or peripheral nervous system lesions.

Design outcomes

Primary

MeasureTime frame
Quality of recovery;Numeric Rating Scales;

Countries

China

Contacts

Public ContactWangning Shangguan

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

sgwning@163.com+86 13587637891

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026